- DRCR/JAEB (Protocol T): Comparative effectiveness study of intravitreal Aflibercept, Bevacizumab, and Ranibizumab in patients with Diabetic Macular Edema
- DRCR/JAEB (Protocol V): Prompt laser + deferred Aflibercept vs Observation + deferred Aflibercept vs Prompt Aflibercep, (1:1:1), for the treatment of Diabetic Macular Edema in treatment-navie patients with very good vision (20/25 or better)
Wet Macular Degeneration:
- Alcon RTH258: A double-masked, multicenter, three-arm study comparing the efficacy and safety of RTH258 versus Afliberecpt in subjects with neovascular age related macular degeneration
- Bausch and Lomb 670: A double-masked study assessing the safety and efficacy of Loteprednol Etabonate ophthalmic gel vs Prednisolone acetate ophthalmic suspension for the treatment of intraocular inflammation following surgery for childhood cataract
At Thomas Eye Group, our study participants are very important to us, and we provide them with exceptional care and attention. We are always seeking participants for current and future studies. If you are interested in participating, please contact our research coordinator, Kathy Wynne, at 404-705-5750.